Compass Therapeutics, Inc. (CMPX)
2.53
+0.13
(+5.42%)
USD |
NASDAQ |
Aug 25, 16:00
2.50
-0.03
(-1.19%)
After-Hours: 19:59
Compass Therapeutics Net Income (Quarterly) : -25.15M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -25.15M |
| March 31, 2026 | -18.32M |
| December 31, 2025 | -15.72M |
| September 30, 2025 | -14.26M |
| June 30, 2025 | -19.88M |
| March 31, 2025 | -16.63M |
| December 31, 2024 | -15.03M |
| September 30, 2024 | -10.48M |
| June 30, 2024 | -13.08M |
| March 31, 2024 | -10.79M |
| December 31, 2023 | -13.42M |
| September 30, 2023 | -9.964M |
| June 30, 2023 | -11.28M |
| March 31, 2023 | -7.837M |
| December 31, 2022 | -11.59M |
| Date | Value |
|---|---|
| September 30, 2022 | -11.98M |
| June 30, 2022 | -8.494M |
| March 31, 2022 | -7.162M |
| December 31, 2021 | -12.98M |
| September 30, 2021 | -5.975M |
| June 30, 2021 | -55.80M |
| March 31, 2021 | -7.422M |
| December 31, 2020 | -8.391M |
| September 30, 2020 | -9.15M |
| June 30, 2020 | -5.557M |
| March 31, 2020 | -6.402M |
| December 31, 2019 | -6.612M |
| September 30, 2019 | -8.552M |
| June 30, 2019 | -8.809M |
| March 31, 2019 | -10.77M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Upstream Bio, Inc. | -39.70M |
| ACADIA Pharmaceuticals, Inc. | 31.50M |
| Alnylam Pharmaceuticals, Inc. | 164.49M |
| Anika Therapeutics, Inc. | 3.309M |
| Savara, Inc. | -40.23M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 25.15M |
| EPS Diluted (Quarterly) | -0.1347 |
| Enterprise Value | 285.38M |
| Earnings Yield | -15.91% |
| Normalized Earnings Yield | -15.91 |